Clear cell sarcoma of tendons and aponeuroses: A study of 75 patients

Cancer

Volumn 109, Issue 1, 2007, Pages 109-116

  Kawai, Akira ^a   Hosono, Ako ^a   Nakayama, Robert ^a,b   Matsumine, Akihiko ^c   Matsumoto, Seiichi ^d   Ueda, Takafumi ^e   Tsuchiya, Hiroyuki ^f   Beppu, Yasuo ^a   Morioka, Hideo ^b   Yabe, Hiroo ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c MIE UNIVERSITY   (Japan)

^d CANCER INSTITUTE HOSPITAL   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f KANAZAWA UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Clear cell sarcoma; Malignant melanoma of soft parts; Prognostic factors; Tumor size

Indexed keywords

ALPHA INTERFERON; CAFFEINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; MESNA; NIMUSTINE; VINCRISTINE;

ADULT; APONEUROSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLEAR CELL SARCOMA; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TENDON DISEASE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; FEMALE; HUMANS; MALE; MELANOMA; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA, CLEAR CELL; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TENDONS; TREATMENT OUTCOME;

EID: 33846308162     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22380     Document Type: Article

References (34)

1. Enzinger FM. Clear-cell sarcoma of tendons and aponeuroses: an analysis of 21 cases. Cancer. 1965;18:1163-1174.
2. Chung EB, Enzinger FM. Malignant melanoma of soft parts: a reassessment of clear cell sarcoma. Am J Surg Pathol. 1983;7:405-413.
3. Zucman J, Delattre O, Desmaze C, et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet. 1993;4:341-345.
4. Langezaal SM, Graadt van Roggen JF, Cleton-Jansen AM, Baelde JJ, Hogendoorn PCW. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer. 2001;84:535-538.
5. Panagopoulos I, Mertens F, Debiec-Rychter M, et al. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Int J Cancer. 2002;99:560-567.
6. Antonescu CR, Tschernyavsky SJ, Woodruff JM, Jungbluth AA, Brennan MF, Ladanyi M. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases. J Mol Diagn. 2002;4:44-52.
7. Eckardt JJ, Pritchard DJ, Soule EH. Clear cell sarcoma: a clinicopathologic study of 27 cases. Cancer. 1983;52:1482-1488.
8. Sara AS, Evans HL, Benjamin RS. Malignant melanoma of soft parts (clear cell sarcoma): a study of 17 cases, with emphasis on prognostic factors. Cancer. 1990;65:367-374.
9. El-Naggar AK, Ordonez NG, Sara A, McLemore D, Batsakis JG. Clear cell sarcomas and metastatic soft tissue melanomas. Cancer. 1991;67:2173-2179.
10. Lucas DR, Nascimento AG, Sim FH. Clear cell sarcoma of soft tissues: Mayo Clinic experience with 35 cases. Am J Surg Pathol. 1992;16:1197-1204.
11. Montgomery EA, Meis JM, Ramos AG, Frisman DM, Martz KL. Clear cell sarcoma of tendons and aponeuroses: a clinicopathologic study of 58 cases with analysis of prognostic factors. Int J Surg Pathol. 1993;1:89-100.
12. Deenik W, Mooi WJ, Rutgers EJ, Peterse JL, Hart AA, Kroon BB. Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 30 cases. Cancer. 1999;86:969-975.
13. Finley JW, Hanypsiak B, Mcgrath B, Kraybill W, Gibbs JF. Clear cell sarcoma: the Roswell Park experience. J Surg Oncol. 2001;77:16-20.
14. Ferrari A, Casanova M, Bisogno G, et al. Clear cell sarcoma of tendons and aponeuroses in pediatric patients: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group. Cancer. 2002;94:3269-3276.
15. ARF pathway in clear cell sarcoma. Cancer Sci. 2004;95:651-655.
16. Naito N, Kawai A, Ouchida M, et al. A reverse transcriptase-polymerase chain reaction assay in the diagnosis of soft tissue sarcomas. Cancer. 2000;89:1992-1998.
17. Sobin LH, Wittekind C, eds. TNM classification of malignant tumors. 6th ed. New York: John Wiley & Sons, Inc.; 2002.
18. World Health Organization. Handbook for reporting results of cancer treatment. Geneva: World Health Organization; 1979.
19. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
20. Cox D. Regression models and life-tables. J R Stat Soc B. 1972;34:187-220.
21. Yokoyama R, Mukai K, Hirota T, Beppu Y, Fukuma H. Primary malignant melanoma (clear cell sarcoma) of bone. Cancer. 1996;77:2471-2475.
22. Gottlieb JA, Baker LH, O'Bryan RM, et al. Adriamycin (NSC-123127) used alone and in combination for soft tissue and bony sarcomas. Cancer Chemother Rep. 1975;3:271-282.
23. Elias A, Ryan L, Sulkes A, Collins J, Aisner J, Antman KH. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol. 1989;7:1208-1216.
24. Bajetta E, DelVecchio M, Bernard-Marty C, et al. Metastatic melanoma: chemotherapy. Semin Oncol. 2002;29:427-445.
25. Tsuchiya H, Tomita K, Yamamoto N, Mori Y, Asada N. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma. Anticancer Res. 1998;18:3651-3656.
26. Tsuchiya H, Tomita K, Mori Y, Asada N, Yamamoto N. Marginal excision for osteosarcoma with caffeine-assisted chemotherapy. Clin Orthop. 1999;358:27-35.
27. Al-Refaie WB, Ali MW, Chu DZ, Paz IB, Blair SL. Clear cell sarcoma in the era of sentinel lymph node mapping. J Surg Oncol. 2004;87:126-129.
28. Picciotto F, Zaccagna A, Derosa G, et al. Clear cell sarcoma (malignant melanoma of soft parts) and sentinel lymph node biopsy. Eur J Dermatol. 2005;15:46-48.
29. Radstone DJ, Revell PA, Mantell BS. Clear cell sarcoma of tendons and aponeuroses treated with bleomycin and vincristine. Br J Radiol. 1979;52:238-241.
30. Steger GG, Wrba F, Mader R, Schlappack O, Dittrich C, Rainer H. Complete remission of metastasised clear cell sarcoma of tendons and aponeuroses. Eur J Cancer. 1991;27:254-256.
31. Boulikas T, Vougiouka M. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs. Oncol Rep. 2004;11:559-595.
32. Karakousis CP, Holtermann OA, Holyoke ED. Cis-dichlorodiammineplatinum (II) in metastatic soft tissue sarcomas. Cancer Treat Rep. 1979;63:2071-2075.
33. Budd GT, Metch B, Balcerzak SP, Fletcher WS, Baker LH, Mortimer JE. High-dose cisplatin for metastatic soft tissue sarcoma. Cancer. 1990;65:866-869.
34. Demetri GD, Elias AD. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Hematol Oncol Clin North Am. 1995;9:765-785.